Wei Lin - 10 Jun 2024 Form 4 Insider Report for 2seventy bio, Inc. (TSVT)

Role
Director
Signature
/s/ Iya Kessler, Attorney-in-Fact
Issuer symbol
TSVT
Transactions as of
10 Jun 2024
Transactions value $
$0
Form type
4
Filing time
12 Jun 2024, 18:53:34 UTC
Previous filing
29 Mar 2024
Next filing
20 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TSVT Common Stock Award $0 +12.1K +57.93% $0.00 32.9K 10 Jun 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TSVT Stock Options (Right to buy) Award $0 +24.1K $0.00 24.1K 10 Jun 2024 Common Stock 24.1K $3.93 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted stock units vest 100% on the earlier of June 10, 2025 or the date of the next annual meeting of stockholders of 2seventy bio, Inc.
F2 This option vests 100% on the earlier of June 10, 2025 or the date of the next annual meeting of stockholders of 2seventy bio, Inc.

Remarks:

Exhibit 24 Power of Attorney